“A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 465 Patients 2 Years and Older with Impetigo”, J of Skin, vol. 1, no. 3.1, p. s104, Oct. 2017, doi: 10.25251/skin.1.supp.103.